In silico analysis of the RNA-seq profiles indicated an imbalanced expression of high matriptase and low prostasin, and their cognate protease inhibitors in B-cell lymphoma patient specimens. The gene discussed is ST14; the disease is B-cell non-Hodgkin lymphoma.